30 12017 Dr Naza M Ali Antifungal Drugs Unlike bacteria fungi are eukaryotic Fungal infections are generally resistant to antibiotics used in the treatment of bacterial ID: 814721
Download The PPT/PDF document "Antifungal drugs Lec 18" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Antifungal drugs
Lec
18
30 -1-2017
Dr.
Naza
M. Ali
Slide2Slide3Antifungal Drugs
Unlike bacteria, fungi are eukaryotic.
Fungal infections are generally resistant to
antibiotics used in the treatment of bacterial
infections, and conversely, bacteria are resistant to
antifungal agents.
Infectious diseases caused by fungi are called mycoses, they are often chronic in nature.
Slide4Mycoses divided into:
Cutaneous
mycoses
:
Infection are superficial and only involve the
(skin, hair, nails).
Subcutaneous mycoses
:
Fungi that grow in soil and on vegetation and
are introduced into subcutaneous tissue
through trauma.
Slide5Systemic mycoses
:
I
nfections result from inhalation of the spores
of dimorphic fungi that have their saprophytic
mold forms in the soil.
are most
difficult to treat which are often life
threatening.
Slide6Mechanism of drug acting on fungi
Alter cell membrane permeability
2. Block nucleic acid synthesis
3. Disrupt microtubule functions
Slide7Drugs for subcutaneous
and systemic fungal infections
1.
Amphoteracin
B
2.
Flucytosine
5-FC
3.
Azole
antifungal agents:
-
Ketoconazole
-
Fluconazole
-
Itraconazole
-
Voriconazole
-
Posaconazole
(new)
Slide84.
Echinocandins
-
Caspofungin
-
Micafungin
Slide9Amphoteracin
B
Is a naturally occurring
polyene
macrolide
antibiotic produced by
Streptomyces
nodosus
.
Is the drug of choice for the treatment of life-threatening systemic mycoses.
Conventional
amphotericin
(
amphotericin
B
deoxycholate
, the
nonlipid
formulation)
has undergone several formulation improvements to reduce the incidence of side effects
(
nephrotoxicity).
Slide10The drug is used in combination with
flucytosine
to achieve more rapid sterilization of the CSF.
Amphotericin
B is either fungicidal or
fungistatic
,
depending on organism and concentration of the drug.
It is often used for initial induction regiments before follow up treatment with an
azole
.
Slide11It has
widest antifungal agents spectrum
than any
agents and the drug of choice for systemic most
infections caused by
Aspergillus
,
Blastomyces
, Candida
albicans
,
Cryptococcus,
Histoplasma
and
Mucor
.
it is usually given by slow IV infusion.
In case of fungal meningitis( by
intrathecal
route).
Local administration in treatment of
mycotic
corneal ulcer
Slide12Slide13Mechansim
of action of
Amphoteracin
B
I
s a
polyene
macrolide related to
nystatin
polyenes
are molecules with both hydrophilic &
lipophilic characteristics.
Several amphotericin B molecules bind to
ergosterol
in the plasma membranes of fungal cells, and cause
the formation of artificial pores (channels).
The pores disrupt membrane function, allowing
electrolytes and small molecules to leak from the cell,
resulting in cell death.
Slide14Slide15Resistance:
Fungal resistance, is associated with decreased
ergosterol
content of the fungal membrane.
Slide16Pharmacokinetics:
Amphotericin B
is used by slow, (IV) infusion
Is insoluble in water, and injectable preparations require the addition of sodium
deoxycholate
, which produces a soluble colloidal dispersion.
The more dangerous
intrathecal
route is chosen for the treatment of meningitis.
Slide17Slide18Slide19Amphotericin B has also been formulated with a
variety of artificial lipids that form liposomes
.
Amphotericin B is extensively bound to plasma protein.
Inflammation favors penetration into various body fluids.
Adverse
effects
Amphotericin B has a low therapeutic index
A total adult daily dose should not exceed
1.5 mg/kg
Small test doses are usually administered to avoid
anaphylaxis or convulsions
Slide21Fever & chills
:
These occur most commonly 1-3 hours after
starting IV, but they usually subside with repeated
administration of the drug.
Premedication with an antipyretic or a corticosteroid
helps to prevent problem.
Slide222. R
enal impairment
:
Azotemia (elevated blood urea)
adequate hydration can decrease its severity.
3. Hypotension:
A shock-like fall in blood pressure
4. Anemia
5. Neurologic effects
Slide23